PDC-748 is an herbal-based anti-tussive drug, being developed by the Pharmaceutical Industry Technology and Development Center (PITDC). With the establishment of the newly formed strategic alliance, consisting of the PITDC, PhytoHealth, and SunTen Phytotech, PDC-748 is now being co-developed to proceed with the first human clinical trial in Taiwan and applying for US FDA approval to proceed with multi-center clinical trials. STPT, being a global leader in the development and quality control of herbal medicines, is responsible for the Chemistry, Manufacturing and Control (CMC) of PDC-748.